Progress about the fibro-adipose vascular anomaly: A review

Yi-Ran Sun,Ming-Li Zou,Si-Ming Yuan
DOI: https://doi.org/10.1097/md.0000000000037225
IF: 1.6
2024-02-17
Medicine
Abstract:Fibro-adipose vascular anomaly (FAVA) is a rare congenital vascular malformation which is characterized by phlebectasia and fibrofatty tissue replacement of muscle, lymphatic involvement, and venous thrombosis. [ 1 ] It was first reported in 2014 by Alomari et al at Boston Children Hospital and was included as a provisionally unclassified vascular anomaly in the 22nd International Society for the Study of Vascular Anomalies (ISSVA). [ 2 , 3 ] The muscles of the extremities typically manifest as FAVA. It is often considered a slow-growing mass and its first symptom is mostly persistent and progressive pain. Owing to the above symptoms together with the lack of flow on ultrasound and anatomical location, FAVA has a high misdiagnosis rate. It often overlaps with other vascular malformations and tumors such as intermuscular hemangioma, angiolipoma, VM with muscle contracture and so on. Repeated surgical resection and interventional sclerotherapy lead to worsening symptoms and irreversible dysfunction, causing constant pain to the patient. Therefore, clear diagnosis and early surgery are extremely important for this disease. Our article provides a series of summaries of the clinical symptoms, pathogenesis, and treatment options of FAVA, hoping to provide reference guidelines for clinical treatment.
medicine, general & internal
What problem does this paper attempt to address?